Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 152 articles:
HTML format



Single Articles


    June 2022
  1. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    PubMed     Abstract available


    May 2022
  2. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    PubMed     Abstract available


  3. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    PubMed    


  4. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    PubMed    


    April 2022
  5. CIAMPI R, Romei C, Ramone T, Matrone A, et al
    Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Apr 26. pii: 6574259. doi: 10.1210.
    PubMed     Abstract available


  6. VINCZE S, Peters NV, Kuo CL, Brown TC, et al
    GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2022;107:e2021-e2026.
    PubMed     Abstract available


  7. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    PubMed     Abstract available


  8. HUANG L, Feng X, Yang W, Li X, et al
    Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
    PubMed     Abstract available


    March 2022
  9. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
    Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
    J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
    PubMed     Abstract available


  10. BOUCAI L, Tuttle RM
    Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
    PubMed    


  11. XING M
    Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
    PubMed    


    February 2022
  12. WENG HY, Yan T, Qiu WW, Fan YB, et al
    The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  13. ALEXANDER EK
    Novel Genomic Roadmaps and Their Clinical Translation Ahead.
    J Clin Endocrinol Metab. 2022;107:e886-e887.
    PubMed    


  14. HAY ID, Lee RA, Charboneau JW
    Efficacy of ethanol ablation in long-term local control of neck nodal metastases in adult papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2022 Jan 14. pii: 6507732. doi: 10.1210.
    PubMed    


  15. JANKOVIC MILJUS J, Guillen-Sacoto MA, Makiadi-Alvarado J, Wert-Lamas L, et al
    Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence.
    J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503735. doi: 10.1210.
    PubMed     Abstract available


    December 2021
  16. STAN MN, Papaleontiou M, Schmitz JJ, Castro MR, et al
    Non-surgical management of thyroid nodules - the role of ablative therapies.
    J Clin Endocrinol Metab. 2021 Dec 25. pii: 6483061. doi: 10.1210.
    PubMed     Abstract available


  17. ROTONDI M, Chiovato L
    Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
    J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
    PubMed    


  18. FRICH PS, Sigstad E, Berstad AE, Holgersen KF, et al
    Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469671. doi: 10.1210.
    PubMed     Abstract available


  19. ASAMOAH EO, Caraballo G, Castro MR
    Identifying and addressing Health disparities in Thyroid Cancer Care.
    J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454343. doi: 10.1210.
    PubMed    


    November 2021
  20. BOUCAI L, Seshan V, Williams M, Knauf JA, et al
    Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
    J Clin Endocrinol Metab. 2021 Nov 23. pii: 6433608. doi: 10.1210.
    PubMed     Abstract available


  21. NIETO HR, Thornton CEM, Brookes K, de Menezes AN, et al
    Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
    J Clin Endocrinol Metab. 2021 Nov 16. pii: 6429719. doi: 10.1210.
    PubMed     Abstract available


  22. WEI Y, Zhao ZL, Wu J, Peng LL, et al
    Response to Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427797. doi: 10.1210.
    PubMed    


  23. YANG S, Xu X
    Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427798. doi: 10.1210.
    PubMed    


  24. LI H, Zhou X, Wang G, Hua D, et al
    CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Nov 9. pii: 6423845. doi: 10.1210.
    PubMed     Abstract available


    October 2021
  25. ROH E, Noh E, Hwang SY, Kim JA, et al
    Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
    PubMed     Abstract available


  26. RADHAKRISHNAN A, Reyes-Gastelum D, Abrahamse P, Gay B, et al
    Physician specialties involved in thyroid cancer diagnosis and treatment: Implications for improving healthcare disparities.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6411790. doi: 10.1210.
    PubMed     Abstract available


  27. KOH J, Zhang R, Roman S, Duh QY, et al
    Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
    J Clin Endocrinol Metab. 2021;106:3168-3183.
    PubMed     Abstract available


  28. SAPONARO F, Pardi E, Mazoni L, Borsari S, et al
    Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
    J Clin Endocrinol Metab. 2021;106:e4565-e4579.
    PubMed     Abstract available


  29. NILUBOL N
    "Cutting the Support" to improve treatment efficacy in thyroid cancer by targeting tumor microenvironment.
    J Clin Endocrinol Metab. 2021 Oct 20. pii: 6406379. doi: 10.1210.
    PubMed    


  30. BROSE MS, Panaseykin Y, Konda B, de La Fouchardiere C, et al
    A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Oct 19. pii: 6401965. doi: 10.1210.
    PubMed     Abstract available


  31. CHANDER NR, Chidambaram S, Van Den Heede K, DiMarco AN, et al
    Correlation of pre-operative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6395413. doi: 10.1210.
    PubMed     Abstract available


  32. GOLDFARB M, Christison-Lagay E, Rastatter J, Wasserman J, et al
    "Young children are not the same as adolescents when it comes to treating thyroid cancer".
    J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381652. doi: 10.1210.
    PubMed    


    September 2021
  33. SINGH P, Bhadada SK, Dahiya D, Saikia UN, et al
    GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    J Clin Endocrinol Metab. 2021;106:e4084-e4096.
    PubMed     Abstract available


  34. POMA AM, Viola D, Macerola E, Proietti A, et al
    Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
    J Clin Endocrinol Metab. 2021;106:e4109-e4117.
    PubMed     Abstract available


  35. LIN S, Zhu Y, Ji C, Yu W, et al
    METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375332. doi: 10.1210.
    PubMed     Abstract available


  36. KIM BW
    Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
    J Clin Endocrinol Metab. 2021 Sep 23. pii: 6374549. doi: 10.1210.
    PubMed     Abstract available


  37. DEKKER BL, Links MH, Muller Kobold AC, Swart-Busscher LG, et al
    Low iodine diet of four days is sufficient preparation for 131I therapy in differentiated thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Sep 17. pii: 6371836. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  38. SINGH P, Bhadada SK, Arya AK, Saikia UN, et al
    Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis.
    J Clin Endocrinol Metab. 2021 Aug 28. pii: 6358989. doi: 10.1210.
    PubMed     Abstract available


  39. REDLICH A, Luster M, Lorenz K, Lessel L, et al
    Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Aug 20. pii: 6355728. doi: 10.1210.
    PubMed     Abstract available


  40. GIOVANELLA L, Garo ML, Ceriani L, Paone G, et al
    Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 12. pii: 6348893. doi: 10.1210.
    PubMed     Abstract available


  41. HAYES AR, Crawford A, Al Riyami K, Tang C, et al
    Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
    J Clin Endocrinol Metab. 2021 Aug 11. pii: 6348246. doi: 10.1210.
    PubMed     Abstract available


  42. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
    Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  43. CIAPPUCCINI R, Saguet-Rysanek V, Giffard F, Licaj I, et al
    PSMA expression in differentiated thyroid cancer: association with radioiodine, 18FDG uptake, and patient outcome.
    J Clin Endocrinol Metab. 2021 Jul 31. pii: 6332894. doi: 10.1210.
    PubMed     Abstract available


  44. IESATO A, Li S, Roti G, Hacker MR, et al
    Lenvatinib targets PDGFR-beta pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327813. doi: 10.1210.
    PubMed     Abstract available


  45. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  46. TAO Y, Wang F, Shen X, Zhu G, et al
    BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 17. pii: 6323355. doi: 10.1210.
    PubMed     Abstract available


  47. GIANI C, Torregrossa L, Ramone T, Romei C, et al
    Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 3. pii: 6291802. doi: 10.1210.
    PubMed     Abstract available


  48. YANG S, Xu X
    Letter to the Editor from [Xiequn Xu]: (Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study)).
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312741. doi: 10.1210.
    PubMed    


    June 2021
  49. PAULSSON JO, Rafati N, DiLorenzo S, Chen Y, et al
    Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
    J Clin Endocrinol Metab. 2021 Jun 25. pii: 6309631. doi: 10.1210.
    PubMed     Abstract available


  50. RADEBE L, van der Kaay DCM, Wasserman JD, Goldenberg A, et al
    Predicting Malignancy with Pediatric Thyroid Nodules: Early Experience in Machine Learning for Clinical Decision Support.
    J Clin Endocrinol Metab. 2021 Jun 23. pii: 6308313. doi: 10.1210.
    PubMed     Abstract available


  51. MANIAKAS A, Henderson YC, Hei H, Peng S, et al
    Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity.
    J Clin Endocrinol Metab. 2021 Jun 19. pii: 6306517. doi: 10.1210.
    PubMed     Abstract available


  52. TIAN T, Xu Y, Zhang X, Liu B, et al
    Prognostic implications of pre-ablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304758. doi: 10.1210.
    PubMed     Abstract available


  53. LIMBACH AL, Sipos JA
    Indeterminate thyroid nodules: the hazy genomic landscape coming into focus.
    J Clin Endocrinol Metab. 2021 Jun 16. pii: 6303548. doi: 10.1210.
    PubMed    


  54. HENDERSON YC, Mohamed ASR, Maniakas A, Chen Y, et al
    A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Jun 12. pii: 6297567. doi: 10.1210.
    PubMed     Abstract available


    May 2021
  55. HU MI, Waguespack SG, Dosiou C, Ladenson PW, et al
    Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 May 19. pii: 6278308. doi: 10.1210.
    PubMed     Abstract available


  56. SUTEAU V, Seegers V, Munier M, Ben Boubaker R, et al
    G Protein-Coupled Receptors in radioiodine-refractory thyroid cancer in the Era of Precision Medicine.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6277036. doi: 10.1210.
    PubMed     Abstract available


  57. PITT SC, Haymart MR
    Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer.
    J Clin Endocrinol Metab. 2021 May 13. pii: 6274981. doi: 10.1210.
    PubMed    


  58. RAUE F, Bruckner T, Frank-Raue K
    Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2021 May 11. pii: 6273583. doi: 10.1210.
    PubMed     Abstract available


    April 2021
  59. VALERIO L, Guidoccio F, Giani C, Tardelli E, et al
    [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival.
    J Clin Endocrinol Metab. 2021 Apr 26. pii: 6253809. doi: 10.1210.
    PubMed     Abstract available


  60. LI R, Li G, Wang Y, Bao T, et al
    Psychological distress and sleep disturbance throughout thyroid nodules screening, diagnosis and treatment.
    J Clin Endocrinol Metab. 2021 Apr 8. pii: 6217326. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  61. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Exceptionality of Distant Metastases in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    J Clin Endocrinol Metab. 2021 Mar 31. pii: 6206751. doi: 10.1210.
    PubMed     Abstract available


  62. CHERELLA CE, Richman DM, Liu E, Frates MC, et al
    Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Mar 29. pii: 6199870. doi: 10.1210.
    PubMed     Abstract available


  63. LIN YS, Zhang X, Wang C, Liu YQ, et al
    Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 26. pii: 6189101. doi: 10.1210.
    PubMed     Abstract available


  64. SEO GH, Ae Kong K, Kim BS, Seo YK, et al
    Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-Based Study.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6184125. doi: 10.1210.
    PubMed     Abstract available


  65. MALCHOFF CD
    Inherited Risk Factors for Nonmedullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Mar 19. pii: 6178882. doi: 10.1210.
    PubMed    



  66. Corrigendum to: "Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study".
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174651. doi: 10.1210.
    PubMed    


  67. WALLNER LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al
    Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 4. pii: 6158968. doi: 10.1210.
    PubMed     Abstract available


  68. XI C, Zhang Q, Song HJ, Shen CT, et al
    Pregnancy does not affect the Prognoses of Differentiated Thyroid Cancer Patients with Lung Metastases.
    J Clin Endocrinol Metab. 2021 Mar 1. pii: 6155712. doi: 10.1210.
    PubMed     Abstract available


    February 2021
  69. CHEN DW, Reyes-Gastelum D, Hawley ST, Wallner LP, et al
    Unmet Information Needs Among Hispanic Women with Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154483. doi: 10.1210.
    PubMed     Abstract available


  70. LI CW, Shi X, Ma B, Wang YL, et al
    A Four Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154371. doi: 10.1210.
    PubMed     Abstract available


  71. CESAREO R, Manfrini S, Pasqualini V, Ambrogi C, et al
    Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study).
    J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145113. doi: 10.1210.
    PubMed     Abstract available


  72. ALEXANDER EK
    From the Tip to the Iceberg below - Evolving our Molecular Understanding of Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 Feb 16. pii: 6137555. doi: 10.1210.
    PubMed    


  73. ZAYED AA, Amarin JZ, Al-Ani AT, Altell TL, et al
    Association of parental consanguinity with papillary thyroid carcinoma: a case-control study.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135109. doi: 10.1210.
    PubMed     Abstract available


  74. CHEN D, Tan Y, Li Z, Li W, et al
    Organoid cultures derived from patients with papillary thyroid cancer.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125726. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  75. PANAGIOTOU G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al
    Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans.
    J Clin Endocrinol Metab. 2021 Jan 25. pii: 6119546. doi: 10.1210.
    PubMed     Abstract available


  76. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
    Plasma cell free DNA to differentiate malignant from benign thyroid nodules.
    J Clin Endocrinol Metab. 2021 Jan 21. pii: 6105060. doi: 10.1210.
    PubMed     Abstract available


  77. CHONG AS, Nikiforov YE, Condello V, Wald AI, et al
    Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2021 Jan 18. pii: 6103949. doi: 10.1210.
    PubMed     Abstract available


  78. ZHANG L, Ren Z, Su Z, Liu Y, et al
    Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
    J Clin Endocrinol Metab. 2021 Jan 11. pii: 6082745. doi: 10.1210.
    PubMed     Abstract available


  79. WAN D, Yang X, Li G, Du Y, et al
    A Set of Markers Related to Viral-Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Jan 4. pii: 6062460. doi: 10.1210.
    PubMed     Abstract available


  80. ZHANG H, Zhang Z, Liu X, Duan H, et al
    DNA methylation haplotype block markers efficiently discriminate follicular thyroid carcinoma from follicular adenoma.
    J Clin Endocrinol Metab. 2021 Jan 4. pii: 6062414. doi: 10.1210.
    PubMed     Abstract available


  81. MURPHY CF, Stratford N, Docherty NG, Moran B, et al
    A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    J Clin Endocrinol Metab. 2021;106:e204-e216.
    PubMed     Abstract available


    December 2020
  82. LIU Y, Wu S, Zhou L, Guo Y, et al
    Pitfalls in RET fusion detection using break-apart FISH probes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2020 Dec 31. pii: 6056485. doi: 10.1210.
    PubMed     Abstract available


  83. NIES M, Vassilopoulou-Sellin R, Bassett RL, Yedururi S, et al
    Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape.
    J Clin Endocrinol Metab. 2020 Dec 31. pii: 6056477. doi: 10.1210.
    PubMed     Abstract available


  84. GRANI G, Lamartina L, AlfO M, Ramundo V, et al
    Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk.
    J Clin Endocrinol Metab. 2020 Dec 30. pii: 6055578. doi: 10.1210.
    PubMed     Abstract available


  85. PITT SC, Yang N, Saucke MC, Marka N, et al
    Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
    J Clin Endocrinol Metab. 2020 Dec 29. pii: 6054975. doi: 10.1210.
    PubMed     Abstract available


  86. ZHU CY, Donangelo I, Gupta D, Nguyen DT, et al
    Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    J Clin Endocrinol Metab. 2020 Dec 2. pii: 6015927. doi: 10.1210.
    PubMed     Abstract available


  87. DAMJANOVIC SS, Antic JA, Elezovic-Kovacevic VI, Dundjerovic DM, et al
    ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    November 2020
  88. MOON JH, Ryu CH, Cho SW, Choi JY, et al
    Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.
    J Clin Endocrinol Metab. 2020 Nov 28. pii: 6009064. doi: 10.1210.
    PubMed     Abstract available


  89. CAPEZZONE M, Sagnella A, Pilli T, Maino F, et al
    Role of Age at Diagnosis in Defining Potential Familial Non-Medullary Thyroid Cancer in Kindreds with Only Two Affected Members.
    J Clin Endocrinol Metab. 2020 Nov 11. pii: 5974121. doi: 10.1210.
    PubMed     Abstract available


  90. ENDO M, Porter K, Long C, Azaryan I, et al
    Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With Surgery.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    October 2020
  91. WASSNER AJ
    Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943497. doi: 10.1210.
    PubMed    


  92. BROOME DT, Naples R, Bailey R, Tekin Z, et al
    Use of Preoperative Imaging in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2020 Oct 29. pii: 5942949. doi: 10.1210.
    PubMed     Abstract available


  93. CAO XJ, Liu J, Zhu YL, Qi L, et al
    Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study.
    J Clin Endocrinol Metab. 2020 Oct 27. pii: 5940804. doi: 10.1210.
    PubMed     Abstract available


  94. YANG S, Jin C, Xu X
    Letter to the Editor from Shijie Yang et al: US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study.
    J Clin Endocrinol Metab. 2020 Oct 22. pii: 5936021. doi: 10.1210.
    PubMed    


    September 2020
  95. SHI X, Li CW, Tan LC, Wen SS, et al
    Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3 and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    J Clin Endocrinol Metab. 2020 Sep 30. pii: 5916419. doi: 10.1210.
    PubMed     Abstract available


  96. KITAHARA CM, Sosa JA, Shiels MS
    Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000-2017.
    J Clin Endocrinol Metab. 2020 Sep 28. pii: 5912267. doi: 10.1210.
    PubMed     Abstract available


  97. RINGEL MD
    New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2020 Sep 25. pii: 5911817. doi: 10.1210.
    PubMed     Abstract available


  98. METOVIC J, Vignale C, Annaratone L, Osella-Abate S, et al
    The oncocytic variant of poorly differentiated thyroid carcinoma shows a specific immune-related gene expression profile.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906602. doi: 10.1210.
    PubMed     Abstract available


  99. ZHI J, Zhang P, Zhang W, Ruan X, et al
    Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing TsMHC-II-mediated Immune Recognition.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906618. doi: 10.1210.
    PubMed     Abstract available


  100. BUTTNER M, Locati LD, Pinto M, Araujo C, et al
    Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer.
    J Clin Endocrinol Metab. 2020 Sep 11. pii: 5904489. doi: 10.1210.
    PubMed    


  101. SINGH P, Bhadada SK, Dahiya D, Arya AK, et al
    Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  102. FULLER S, Del Rivero J, Venzon D, Ilanchezhian M, et al
    Pulmonary Function in Patients With Multiple Endocrine Neoplasia 2B.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    August 2020
  103. IWADATE M, Mitsutake N, Matsuse M, Fukushima T, et al
    The clinicopathological results of thyroid cancer with BRAFV600E mutation in the young population of Fukushima.
    J Clin Endocrinol Metab. 2020 Aug 22. pii: 5895513. doi: 10.1210.
    PubMed     Abstract available


  104. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Distant metastasis in pediatric and adolescent differentiated thyroid cancer: Clinical outcomes and risk factor analyses.
    J Clin Endocrinol Metab. 2020 Aug 19. pii: 5894448. doi: 10.1210.
    PubMed     Abstract available


  105. CORDERO-BARREAL L, Caleiras E, Lopez de Maturana E, Monteagudo M, et al
    CD133 expression in medullary thyroid cancer cells identifies patients with poor prognosis.
    J Clin Endocrinol Metab. 2020 Aug 13. pii: 5892412. doi: 10.1210.
    PubMed     Abstract available


  106. CHANG DJ, Leung AM
    Who's Going to Manage the Thyroid Cancer?
    J Clin Endocrinol Metab. 2020 Aug 10. pii: 5890516. doi: 10.1210.
    PubMed    


  107. MATRONE A, Faranda A, Latrofa F, Gambale C, et al
    Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  108. KIKUMORI T, Ichikawa T, Inaishi T, Miyajima N, et al
    Measurement of the AST to LD Ratio in Parathyroid Tissue Suspension Can Precisely Differentiate a Hyperfunctioning Parathyroid.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    July 2020
  109. LAN X, Cao J, Ye K, Zhang C, et al
    TCR-seq identifies distinct repertoires of distant metastatic and non-distant metastatic thyroid tumors.
    J Clin Endocrinol Metab. 2020 Jul 16. pii: 5872586. doi: 10.1210.
    PubMed     Abstract available


  110. RADHAKRISHNAN A, Reyes-Gastelum D, Gay B, Hawley ST, et al
    Primary care provider involvement in thyroid cancer survivorship care.
    J Clin Endocrinol Metab. 2020 Jul 8. pii: 5868790. doi: 10.1210.
    PubMed     Abstract available


  111. ALEXANDER EK
    Utility of Minimally Invasive Treatment for Papillary Microcarcinoma, Acknowledging Most Require No Treatment at All.
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


  112. PITOIA F, Smulever A, Jerkovich F
    "Letter to the Editor: Foundation OneTM Genomic Interrogation of Thyroid Cancers in Patients with Metastatic Disease Requiring Systemic Therapy".
    J Clin Endocrinol Metab. 2020 Jul 1. pii: 5865799. doi: 10.1210.
    PubMed    


    June 2020
  113. PACINI F
    Does microscopic extrathyroidal extension confer an higher risk of recurrence in patients with well differentiated thyroid cancer?
    J Clin Endocrinol Metab. 2020 Jun 29. pii: 5864721. doi: 10.1210.
    PubMed    


  114. HONG Z, Xin X, Ying C, Yi L, et al
    Chaperone-mediated autophagy governs progression of papillary thyroid carcinoma via PPARgamma-SDF1/CXCR4 signaling.
    J Clin Endocrinol Metab. 2020 Jun 18. pii: 5859150. doi: 10.1210.
    PubMed     Abstract available


  115. ALZAHRANI AS, Alswailem M, Alswailem AA, Al-Hindi H, et al
    Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel.
    J Clin Endocrinol Metab. 2020 Jun 18. pii: 5859128. doi: 10.1210.
    PubMed     Abstract available


  116. BRADLEY D
    Obesity, Thyroid Nodularity, and Thyroid Cancer: Epiphenomenon or Cause?
    J Clin Endocrinol Metab. 2020 Jun 11. pii: 5856160. doi: 10.1210.
    PubMed    


  117. CHEN L, Xiong L, Hong S, Li J, et al
    Circulating myeloid-derived suppressor cells facilitate invasion of thyroid cancer cells by repressing miR-486-3p.
    J Clin Endocrinol Metab. 2020 Jun 3. pii: 5850994. doi: 10.1210.
    PubMed     Abstract available


  118. GRANI G, Sponziello M, Pecce V, Ramundo V, et al
    Contemporary thyroid nodule evaluation and management.
    J Clin Endocrinol Metab. 2020 Jun 3. pii: 5850848. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  119. JUNG SN, Kang YE, Lee GH, Liu L, et al
    Brn3a/Pou4f1 functions as a tumor suppressor by targeting c-MET/STAT3 signaling in thyroid cancer.
    J Clin Endocrinol Metab. 2020 May 31. pii: 5849340. doi: 10.1210.
    PubMed     Abstract available


  120. CAMPBELL PJ, Kendrew P, Lewer M, Lim EM, et al
    Response to Letter to the Editor: Changes in thyroid function across adolescence: a longitudinal study.
    J Clin Endocrinol Metab. 2020 May 27. pii: 5847824. doi: 10.1210.
    PubMed    


  121. RAVEROT V, Perrin P, Borson-Chazot F
    Letter to the Editor: "Changes in Thyroid Function Across Adolescence: a Longitudinal Study".
    J Clin Endocrinol Metab. 2020 May 27. pii: 5847823. doi: 10.1210.
    PubMed    


  122. WANG G, Wang S, Zhang M, Li Y, et al
    EV PD-L1 is correlated with clinical features and contributes to T cell suppression in pediatric thyroid cancer.
    J Clin Endocrinol Metab. 2020 May 27. pii: 5847668. doi: 10.1210.
    PubMed     Abstract available


  123. INIGUEZ-ARIZA NM, Jasim S, Ryder MM, Chintakuntlawar AV, et al
    Foundation OneTM Genomic Interrogation of Thyroid Cancers in Patients with Metastatic Disease Requiring Systemic Therapy.
    J Clin Endocrinol Metab. 2020 May 18. pii: 5839873. doi: 10.1210.
    PubMed     Abstract available


  124. MAURI G, Giugliano G, Maria Cecilia M, Luca S, et al
    Letter to the Editor: Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
    J Clin Endocrinol Metab. 2020 May 12. pii: 5836400. doi: 10.1210.
    PubMed    


  125. MOLINARO E, Campopiano C, Elisei R
    Response to Letter to the Editor: Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
    J Clin Endocrinol Metab. 2020 May 12. pii: 5836401. doi: 10.1210.
    PubMed    


  126. FUSSEY JM, Beaumont RN, Wood AR, Vaidya B, et al
    Does obesity cause thyroid cancer? A Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 May 11. pii: 5835841. doi: 10.1210.
    PubMed     Abstract available


  127. PAPARODIS RD, Bantouna D, Karvounis E, Imam S, et al
    Higher TSH is not associated with thyroid cancer risk in the presence of thyroid autoimmunity.
    J Clin Endocrinol Metab. 2020 May 11. pii: 5835732. doi: 10.1210.
    PubMed     Abstract available


  128. VIGNERI R, Malandrino P, Russo M
    Is thyroid cancer increasing in incidence and aggressiveness?
    J Clin Endocrinol Metab. 2020 May 4. pii: 5830805. doi: 10.1210.
    PubMed    


    April 2020
  129. LIN HT, Liu FC, Lin SF, Kuo CF, et al
    Familial aggregation and heritability of non-medullary thyroid cancer in an Asia population: A nationwide cohort study.
    J Clin Endocrinol Metab. 2020 Apr 25. pii: 5825279. doi: 10.1210.
    PubMed     Abstract available


  130. LONG M, Zhu Y, Chen Z, Lin S, et al
    Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1alpha and microRNA-146a.
    J Clin Endocrinol Metab. 2020 Apr 18. pii: 5821525. doi: 10.1210.
    PubMed     Abstract available


  131. PANATO C, Vaccarella S, Dal Maso L, Basu P, et al
    Thyroid cancer incidence in India between 2006 and 2014 and impact of overdiagnosis.
    J Clin Endocrinol Metab. 2020 Apr 16. pii: 5820802. doi: 10.1210.
    PubMed     Abstract available


    March 2020
  132. RITTER A, Mizrachi A, Bachar G, Vainer I, et al
    Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
    J Clin Endocrinol Metab. 2020 Mar 27. pii: 5812602. doi: 10.1210.
    PubMed     Abstract available


  133. YUE WW, Qi L, Wang DD, Yu SJ, et al
    US-guided Microwave ablation of Low-risk Papillary thyroid Microcarcinoma: Longer-term results of a Prospective study.
    J Clin Endocrinol Metab. 2020 Mar 21. pii: 5810812. doi: 10.1210.
    PubMed     Abstract available


  134. YAN KL, Li S, Tseng CH, Kim J, et al
    Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017.
    J Clin Endocrinol Metab. 2020 Mar 13. pii: 5804233. doi: 10.1210.
    PubMed     Abstract available


    December 2019
  135. HINDIE E, Ain KB, Zerdoud S, Avram AM, et al
    Association of Radioactive Iodine Treatment of Hyperthyroidism with Cancer Mortality: an Unjustified Warning?
    J Clin Endocrinol Metab. 2019 Dec 26. pii: 5687008. doi: 10.1210.
    PubMed    


  136. MATRONE A, Ceccarini G, Beghini M, Ferrari F, et al
    Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2019 Dec 26. pii: 5687038. doi: 10.1210.
    PubMed     Abstract available


    November 2019
  137. ANGELL TE
    Insights from a real-world study of molecular test performance for indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2019 Nov 25. pii: 5639764. doi: 10.1210.
    PubMed    


  138. CASTELLANA M, Castellana C, Treglia G, Giorgino F, et al
    Performance of five ultrasound risk stratification systems in selecting thyroid nodules for FNA. A meta-analysis.
    J Clin Endocrinol Metab. 2019 Nov 6. pii: 5613652. doi: 10.1210.
    PubMed     Abstract available


    October 2019
  139. SIPOS JA
    The thyroid nodule conundrum: evaluate or leave it alone?
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607891. doi: 10.1210.
    PubMed    


  140. DURANTE C, Grani G
    Clinically silent thyroid cancers: drop those needles and scalpels!
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607921. doi: 10.1210.
    PubMed    


  141. VAN VELSEN EFS, Stegenga MT, van Kemenade FJ, Kam BLR, et al
    Evaluation of the 2015 ATA Guidelines in Patients with Distant Metastatic Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607901. doi: 10.1210.
    PubMed     Abstract available


  142. SAN MARTIN VT, Lawrence L, Bena J, Madhun NZ, et al
    Real World Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
    J Clin Endocrinol Metab. 2019 Oct 26. pii: 5607535. doi: 10.1210.
    PubMed     Abstract available


  143. MOLINARO E, Campopiano MC, Pieruzzi L, Matrone A, et al
    Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center.
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5607347. doi: 10.1210.
    PubMed     Abstract available


    August 2019
  144. ESFANDIARI NH, Hughes DT, Reyes-Gastelum D, Ward KC, et al
    Factors Associated with Diagnosis and Treatment of Thyroid Microcarcinomas.
    J Clin Endocrinol Metab. 2019 Aug 15. pii: 5550196. doi: 10.1210/jc.2019-01219.
    PubMed     Abstract available


    July 2019
  145. ANGELL TE, Maurer R, Wang Z, Kim MI, et al
    A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules.
    J Clin Endocrinol Metab. 2019 Jul 16. pii: 5532036. doi: 10.1210/jc.2019-00664.
    PubMed     Abstract available


    June 2019
  146. GRANI G, Ramundo V, Falcone R, Lamartina L, et al
    Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound.
    J Clin Endocrinol Metab. 2019 Jun 17. pii: 5516551. doi: 10.1210/jc.2019-00962.
    PubMed     Abstract available


    May 2019
  147. LIU Z, Shen X, Liu R, Zhu G, et al
    Stage II Differentiated Thyroid Cancer Is a High-risk Disease in Patients <45/55 Years Old.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492492. doi: 10.1210/jc.2018-02809.
    PubMed     Abstract available


    April 2019
  148. SAPUPPO G, Tavarelli M, Belfiore A, Vigneri R, et al
    Response to Letter to the Editor: [Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different outcomes].
    J Clin Endocrinol Metab. 2019 Apr 24. pii: 5476510. doi: 10.1210/jc.2019-00851.
    PubMed    


  149. BURMEISTER LA, Drake T
    "Letter to the Editor: [Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different outcomes]".
    J Clin Endocrinol Metab. 2019 Apr 24. pii: 5476515. doi: 10.1210/jc.2019-00634.
    PubMed    


  150. MA B, Jiang H, Wen D, Hu J, et al
    Transcriptome analyses identify a metabolic gene signature indicative of dedifferentiation of papillary thyroid cancer.
    J Clin Endocrinol Metab. 2019 Apr 3. pii: 5425396. doi: 10.1210/jc.2018-02686.
    PubMed     Abstract available


    March 2019
  151. DEANDREA M, Trimboli P, Garino F, Mormile A, et al
    Long Term Efficacy of a Single Session RFA of Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372729. doi: 10.1210/jc.2018-02808.
    PubMed     Abstract available


    February 2019
  152. BARRES B, Kelly A, Kwiatkowski F, Batisse-Lignier M, et al
    Stimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342942. doi: 10.1210/jc.2018-02680.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: